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Abstract 
We present an extremely rare case of plexi-
form  neurofibroma  involving  the  hepatic
hilum.  A  24-year  old  woman  who  had  been
diagnosed with neurofibromatosis type 1 was
referred to our hospital for evaluation of an
abdominal mass found on computed tomogra-
phy and progressive aggravation of intermit-
tent  abdominal  pain.  Abdominal  computed
tomography  revealed  a  multilobulated  non-
enhancing  mass  involving  the  celiac  trunk
and hepatic artery, that extended to the hepat-
ic  hilum  through  the  hepatoduodenal  liga-
ment.  Magnetic  resonance  imaging  showed
the  lesion  extending  along  the  intrahepatic
Glisson’s sheath. Based on the imaging find-
ings, the patient was diagnosed to have a neu-
rofibroma, although sarcomatous differentia-
tion  could  not  be  excluded.  The  tumor  was
resected,  leaving  behind  the  intrahepatic
extension,  with  the  aim  of  alleviating  the
abdominal  pain  and  preventing  obstructive
jaundice.  Histopathological  examination
revealed the diagnosis of plexiform neurofi-
broma. At present, three years after the sur-
gery, the patient remains symptom-free, with-
out any evidence of recurrence. 
Introduction 
Plexiform  neurofibroma,  which  is  consid-
ered  pathognomonic  of  neurofibromatosis
type  1  (NF-1),  usually  occurs  in  the  neck,
pelvis, and extremities. Plexiform neurofibro-
ma in the hepatic hilum is an unusual mani-
festation of NF-1 and is extremely rare. We
present the case of a 24-year old woman with
NF-1 diagnosed to have plexiform neurofibro-
ma  involving  the  celiac  trunk,  the  common
hepatic artery, the hepatoduodenal ligament
and the hepatic hilum that showed extension
along the intrahepatic Glisson’s sheath. 
Case Report 
A 24-year old woman who had been diag-
nosed with NF-1 during childhood was referred
to  Fujita  Health  University  Hospital  in
September  2004  for  evaluation  of  an  upper
abdominal mass found on abdominal comput-
ed tomography (CT) at another hospital and
progressive aggravation of intermittent upper
abdominal pain. There was no relevant family
history. Physical examination revealed numer-
ous café-au-lait spots and cutaneous tumors.
In addition to the skin lesions, there was a his-
tory of surgical treatment for scoliosis. All lab-
oratory test results obtained at admission were
all  within  normal  limits.  Abdominal  CT
revealed a multilobulated low-attenuation non-
enhancing mass involving the celiac trunk and
the common hepatic artery, extending to the
hepatic hilum through the hepatoduodenal lig-
ament  (Figure  1).  Hepatic  angiography
showed a normal caliber of the hepatic artery
without  any  irregularity,  and  portography  as
visualized  through  the  superior  mesenteric
artery  revealed  a  patent  portal  vein  without
encasement. On magnetic resonance imaging
(MRI),  the  lesion  was  visualized  as  a
hypointensity on T1-weighted images and as a
hyperintensity  on  T2-weighted  images,  and
was  found  to  extend  along  the  intrahepatic
Glisson’s sheath (Figure 2). On magnetic reso-
nance cholangiopancreatography (MRCP), the
common  bile  duct  and  the  left  hepatic  duct
were slightly depressed, without dilatation of
the  intrahepatic  bile  duct.  Based  on  these
imaging findings, the patient was diagnosed to
have  a  neurofibroma,  although  sarcomatous
differentiation could not be excluded. 
Although MRI findings suggested that the
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Figure 1. Contrast-enhanced computed tomography showing a low-attenuation lesion
involving the celiac axis (CA), the common hepatic artery (CHA), and the portal vein
(PV), and extending into the hepatic hilum (arrows). 
Figure 2. Abdominal MRI (T2-weighted image) showing a hyperintense tumor involving
the hepatoduodenal ligament and the hepatic hilum (arrows), extending along the intra-
hepatic Glisson’s sheath (arrow heads).  [Rare Tumors 2009; 1:e23] [page 67]
tumor was unresectable owing to its intrahep-
atic  extension,  the  tumor  was  removed  in
February 2005, leaving behind the intrahepatic
extension,  with  the  aim  of  alleviating  the
abdominal  pain  and  preventing  obstructive
jaundice. Laparotomy revealed a whitish firm
tumor involving the celiac trunk, the common
hepatic artery, and the hepatoduodenal liga-
ment,  extending  through  the  hepatic  hilum
(Figure 3). Since skeletonization of the hepa-
toduodenal ligament was feasible, the tumor
was resected piecemeal, without any need for
combined resection of the vessels or ducts. 
On  examination  of  the  cut  surface,  the
tumor was whitish, firm, solid, and partially
encapsulated.  Pathological  examination
revealed expansion of the nerve fascicles, with
a multilobulated appearance. The tumor was
chiefly composed of elongated spindle-shaped
cells having wavy nuclei, with a myxoid matrix
(Figure 4A and B). Mucinous change in the
stroma was prominent. These findings were
consistent with the diagnosis of benign plexi-
form neurofibroma. No evidence of malignant
transformation was seen. 
The post-operative course was uneventful.
At present, three years after the surgery, the
patient remains symptom-free, and shows no
evidence of recurrence. 
Discussion 
NF-1, also known as von Recklinghausen’s
disease,  is  a  systemic,  autosomal  dominant
neurocutaneous  syndrome  occurring  at  a
prevalence of one case in 3,000 live births.
1 It
is caused by mutations of the NF1 gene, which
is located on chromosome 17q11.2.
2 Although
many cases are heritable, approximately 30-
50%  of  cases  arise  from  spontaneous  muta-
tions.
1 NF-1  is  characterized  by  café-au-lait
spots, cutaneous neurofibromas, bone malfor-
mations, Lisch nodules, and sometimes, malig-
nant tumors.
1 The average life expectancy of
patients with NF-1 is probably reduced by 10-15
years,  and  malignancy  is  the  most  common
cause  of  death.
2 The  most  characteristic
tumors in patients with NF-1 are neurofibro-
mas which arise from cells of the nerve sheath
and  consist  of  a  mixture  of  Schwann  cells,
fibroblasts, perineurial cells, and mast cells.
3
Plexiform  neurofibroma  is  a  benign  nerve
sheath tumor, which is virtually pathognomon-
ic of NF-1. It consists of the same cell types as
a  cutaneous  fibroma  but  has  an  expanded
extracellular matrix, and its presence is one of
the clinical criteria for the diagnosis of NF-1.
3
The  incidence  of  plexiform  neurofibroma  in
patients with NF-1 has been reported to be 15-
30%.
4,5 It  may  be  present  superficially  or  be
located internally, and consists of proliferation
of cells in the nerve sheath extending across
the length of a nerve, involving multiple fasci-
cles and branches.
6 Although it tends to grow
slowly, growth spurts are seen, particularly in
early childhood and during puberty or pregnan-
cy.
6 Plexiform  neurofibromas  are  at  an
increased  risk  of  developing  into  malignant
peripheral  nerve  sheath  tumors  (MPNSTs).
MPNSTs arise predominantly from pre-exist-
ing plexiform neurofibromas and metastasize
widely and often presage a poor outcome.
3 The
lifetime risk of MPNSTs in patients with NF-1
is estimated to be about 10%.
7
On CT, plexiform neurofibromas are visual-
ized as multilobulated low-attenuation masses,
usually within a major nerve distribution.
8 On
MRI,  the  tumors  are  seen  as  conglomerate
hyperintense masses consisting of innumer-
able neurofibromas with central hypointense
regions,  known  as  the  “target  sign”  on  T2-
weighted images.
8 However, malignant trans-
formation of internal plexiform neurofibromas
into MPNSTs is difficult to assess by imaging
alone. Thus, the diagnosis of MPNSTs requires
biopsy,  but  there  is  substantial  potential  for
sampling error in large plexiform neurofibro-
mas.
6 Although plexiform neurofibromas occur
predominantly  in  the  head  or  neck  in  NF-1
patients,
5 in  approximately  40%  of  patients
with NF-1, lesions are detected by abdominal
or pelvic CT.
9 Internal plexiform lesions in the
abdomen or pelvis are commonly located in the
paraspinal space, sciatic nerve, or perirectal
space.
9 Therefore,  extension  of  a  plexiform
neurofibroma  involving  the  retroperitoneum
and hepatoduodenal ligament into the hepatic
hilum is an unusual manifestation in cases of
NF-1.  A  search  of  PubMed  using  the  terms
“liver”,  “hilum”,  “hilar”,  or  “porta  hepatis”,
and “neurofibroma” revealed only 9 cases of
plexiform neurofibroma in the hepatic hilum
reported to date in the English language litera-
ture.
10-17 All of the 10 cases, including the pres-
ent case, showed retroperitoneal involvement
or intrahepatic extension along the Glisson’s
sheath. Therefore, the imaging features of the
present case are closely similar to those of the
previously  reported  cases.  Rodriguez  et  al.
reported a case with diffuse intrahepatic peri-
portal plexiform neurofibroma and described
the  non-enhancing  low-attenuation  lesions
surrounding central and peripheral periportal
spaces as the “periportal collar sign”, which
was initially described as a finding of rejection
in liver transplantation.
18
Internal plexiform neurofibromas can per-
sist  for  many  years  without  causing  clinical
problems and they usually remain undetected
until incidental detection by an imaging study
or following the development of clinical symp-
toms.
6 When patients have substantial neuro-
logical  deficits  or  disfigurement,  removal  of
plexiform  neurofibromas  poses  challenging
problems because of infiltration by the tumors
of  the  surrounding  tissues  and  nerves,
19
although the current treatment of first choice
for plexiform neurofibromas remains surgery.
Therefore, there is controversy regarding the
optimal timing for surgical intervention. Some
authors advocate early surgery to prevent the
development of major cosmetic and functional
impairment, whereas there is a counter argu-
Case Report
Figure  3.  Laparotomy  revealed  a  whitish
firm tumor involving the hepatoduodenal
ligament and the hepatic hilum (arrows).
Figure 4. (A) Multiple nerve fascicles are expanded by proliferation of tumor cells embed-
ded in a prominent myxoid matrix. (HE stain, x 40). (B) At high magnification, the
tumor was chiefly composed of elongated spindle-shaped cells having wavy nuclei, with
a myxoid matrix. (HE stain, x 400).[page 68] [Rare Tumors 2009; 1:e23]
ment that even small plexiform neurofibromas
can rarely be removed entirely and regrowth
after surgery may occur.
6 Although in the pres-
ent case, based on the MRI findings, the tumor
was deemed as difficult to remove in its entire-
ty owing to its intrahepatic extension, removal
of the tumor was nonetheless attempted in an
attempt  to  alleviate  the  abdominal  pain  and
prevent obstructive jaundice. To the best of our
knowledge, this is the first reported case of
plexiform neurofibroma in the hepatic hilum
in which successful resection was carried out. 
In conclusion, we have reported an unusual
case  of  plexiform  neurofibroma,  unique  in
terms  of  its  location  at  the  hepatic  hilum.
Thus,  the  presence  of  this  tumor  at  this
uncommon location should also be borne in
mind,  especially  in  complaints  of  abdominal
discomfort, and it is essential to periodically
monitor  patients  with  NF-1  for  the  develop-
ment of this tumor because of the possibility of
serious clinical presentations and malignant
transformation. 
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